European perspective on active surveillance for papillary thyroid microcarcinoma—are we ready?
The study is a short summary of the current knowledge on this subject from the European perspective.
Due to the growing population of patients with low‑risk papillary thyroid cancer, active surveillance is increasingly considered worldwide instead of immediate surgical intervention. The study is a short summary of the current knowledge on this subject from the European perspective.
The growing population of patients with low‑risk papillary thyroid carcinoma (PTC) has prompted a global discussion on whether active surveillance (AS) should replace immediate surgical intervention.
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- Disproportionality analysis of adverse events associated with tyrosine kinase inhibitors in gastrointestinal stromal tumors in the FDA adverse event reporting system
- Review of Genomic Testing and SDH Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
- Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
- Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
- UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)